Comparison of the effectiveness of commonly used DMARDs in rheumatoid arthritis.

被引：0
|
作者：
Malinowski, J [1 ]
Sibley, J [1 ]
Pahwa, P [1 ]
Nair, B [1 ]
Dyck, R [1 ]
机构：
[1] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [41] Insulin for rheumatoid arthritis.
    Delicati, L
    LANCET, 1931, 2 : 1434 - 1434
  • [42] Adalimumab in rheumatoid arthritis.
    Moreland L.
    Current Rheumatology Reports, 2004, 6 (5) : 333 - 334
  • [43] Treatment of rheumatoid arthritis.
    Jones, RL
    BRITISH MEDICAL JOURNAL, 1902, 1902 : 1931 - 1931
  • [44] The etiology of rheumatoid arthritis.
    Cecil, RL
    Nicholls, EE
    Stainsby, WJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1931, 181 : 12 - 25
  • [45] The cause of rheumatoid arthritis.
    Garry, TG
    BRITISH MEDICAL JOURNAL, 1913, 1913 : 1185 - 1185
  • [46] Tapering biologic DMARDs in rheumatoid arthritis
    Braverman, Genna
    Bridges, S. Louis
    Moreland, Larry W.
    CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2022, 61
  • [47] Comparison of the Efficacy of DMARDs in Phase 3 Trials of Different Populations Used in FDA Approvals for Rheumatoid Arthritis Since 2010
    Emanuel, Catherine
    Aggarwal, Ajay
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2804 - 2805
  • [48] PREDICTION OF TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USED BIOLOGICAL DMARDS AND TARGETED SYNTHETIC DMARDS
    Koltsova, E.
    Lukina, G.
    Shmidt, E.
    Lytkina, K.
    Zhilyaev, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1211 - 1211
  • [49] Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis
    Zink, A
    Thiele, K
    Huscher, D
    Listing, J
    Sieper, J
    Krause, A
    Gromnica-Ihle, E
    von Hinueber, U
    Wassenberg, S
    Genth, E
    Schneider, M
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 86 - 90
  • [50] THE COST-EFFECTIVENESS OF BIOLOGIC DMARDS IN PATIENTS WITH SEVERE OR MILD-TO-SEVERE RHEUMATOID ARTHRITIS AFTER CONVENTIONAL DMARDS
    Wailoo, A. J.
    Stevenson, M.
    Tosh, J.
    Hernandez, M.
    Stevens, J. W.
    Archer, R.
    Simpson, E.
    Hock, Everson E.
    Scott, D.
    Young, A.
    Paisley, S.
    Williams, K.
    VALUE IN HEALTH, 2014, 17 (07) : A380 - A380
12345